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Abstract: Endogenous estrogens have dramatic and differential effects on classical 
endocrine organ and proliferation. Xenoestrogens are environmental estrogens that have 
endocrine impact, acting as both estrogen agonists and antagonists, but whose effects are 
not well characterized. In this investigation we sought to delineate effects of 
xenoestrogens. Using human cervical cancer cells (HeLa cells) as a model, the effects of 
representative xenoestrogens (Coumestrol-a phytoestrogen, tetrachlorodioxin (TCDD)-a 
herbicide and DDT-a pesticide) on proliferation, cell cycle, and apoptosis were examined. 
These xenoestrogens and estrogen inhibited the proliferation of Hela cells in a dose 
dependent manner from 20 to 120 nM suggesting, that 17-β-estrtadiol and xenoestrogens 
induced cytotoxic effects. Coumestrol produced accumulation of HeLa cells in G2/M 
phase, and subsequently induced apoptosis. Similar effects were observed in estrogen 
treated cells. These changes were associated with suppressed bcl-2 protein and augmented 
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Cyclins A and D proteins. DDT and TCDD exposure did not induce apoptosis. These 
preliminary data taken together, suggest that xenoestrogens have direct, compound-specific 
effects on HeLa cells. This study further enhances our understanding of environmental 
modulation of cervical cancer.  
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1. Introduction 
 
Endogenous estrogens, especially 17-β-estradiol, have significant impact on cell mediated and 
humoral immune and autoimmune responses [1-5]. Derived from plant or industrial synthesis, 
environmental xenobiotics with potential estrogenic or hormonal activities are known as 
xenoestrogens. These compounds are ubiquitous, exhibit bioaccumulation, and act as estrogen agonists 
or antagonists, disrupting normal endocrine axes [6-15]. Xenoestrogens have significantly weaker 
binding affinities than endogenous estrogens to traditional steroid receptors [9,14,15] and their 
medical, environmental, and societal impact is the frequent subject of debate [12,13]. Representative 
xenoestrogens include compounds such as coumestrol, a phytoestrogen found in high levels in legumes 
that acts as an estrogen agonist. Coumestrol has been shown to modulate production of thymic 
hormones [17]. DDT (o,p-dichlorodiphenyltrichloroethane), a synthetic organochlorine pesticide, has a 
weak estrogenic agonist activity (as well as androgen antagonist activity) [21] and has been associated 
with immunosuppression in murine models [22-24] and modulation of cell cycle and apoptosis [25-
27], but its effects on other diseases such as cervical cancer has not been characterized. TCDD 
(tetrachlorodibenzo-p-dioxin), a polychlorinated biphenyl dioxin, has been widely studied with 
variable results, having both estrogen agonist and antagonist activity [6,14,21]. It has also been found 
to modulate cell cycle proteins [29], induce thymic involution [30], and modulate cytokine   
expression [31,32]. Xenoestrogens may act at the cellular and molecular levels, binding to both steroid 
and aryl hydrocarbon receptors exhibiting both dependent and independent receptor modulations of 
specific gene transcriptional elements [29,32-35]. As a result, xenoestrogens have the potential to 
variably modulate cell proliferation, cell cycle progression, apoptosis and cytokine production in much 
the same way as 17-β-estradiol does [36-40]. This modulation is likely to occur in association with 
alterations in bcl-2 or p53 protein levels [29,38,39]. In this investigation, using the HeLa cell line as a 
model we explored xenoestrogen-specific effects. 
 
2. Material and Methods 
 
Reagents and Cell Culture 
 
Human cervical cancer (HeLa) cells were purchased from American Type Culture Collection 
(Rockville, MD), maintained in logarithmic growth, and cultured in DMEM. Cells were cultured in a 
density between 0.1 and 1.0 × 10
6/mL. Medium was deemed complete when supplemented with 10% Int. J. Environ. Res. Public Health 2010, 7          
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fetal bovine serum, 2 mM L-glutamine, 100 U/mL penicillin and 100 μg/mL streptomycin. The cells
 
were cultured in suspension
  at 37°C and 5%
  CO2 in a humidified
  incubator and carried at
  
0.1–2.0 × 10
6 cells/mL,
 passaging two to three
 times weekly as needed.
 Cells were pelleted
 and 
resuspended in fresh
 complete medium in tissue
 culture plates 24 h
 before use in experiments
 to avoid 
any confounding
 gene expression that might
 occur because of handling. Xenoestrogens were dissolved 
in 1,4-dioxane or DMSO with final concentrations of solvent in control or treated cultures < 0.1%. 
 
Proliferation Assay 
 
Cells were cultured in triplicate at 1.0 × 10
6/mL for 72 h, treated with different concentrations  
(0, 20, 40, 60, 80, 90 nM) of 17-β-estradiol, coumestrol, DDT and TCDD. Proliferation was measured 
by determination of total viable cell mass using the CellTiter 96® AQueous Non-Radioactive Cell 
Proliferation Assay Kit (Promega, Madison, WI) according to the manufacturer’s instructions. 
Absorbance at 490 nm was determined on a Bio-Rad (Hercules, CA) plate reader.  
 
Cell Cycle Analysis 
 
Cell cycle analysis was performed as previously described [38,39]. Briefly, 1 × 10
6 cells /mL were 
grown in suspension, harvested by centrifugation, washed, and fixed in 1% paraformaldehyde. After 
washing, the cells were permeabilized in 70% ethanol, washed, and re-suspended in PBS. RNase 
(Sigma) was added at a final concentration of 5 U/mL. Cells were stained with propidium iodide (PI). 
Flow microfluorometry was performed and DNA histograms were generated and analyzed using a 
Becton Dickinson Flowscan (Franklin Lakes, NJ). This method correlates closely with other measures 
of apoptosis including TUNEL and Annexin V staining while providing additional cell cycle 
information [41]. This method also allows for enumeration of the percentages of cells in G0/G1 
(resting phase), S (DNA synthesis phase), G2M (mitotic phase), and hypodiploid or apoptotic 
percentages (those cells containing less than the normal amount of DNA) [41]. 
 
Western Blot Analysis 
 
For Western analysis, 5 × 10
6 cells were cultured, treated with various concentrations of estrogen, 
coumestrol, DDT and TCDD compounds. Total protein concentration was determined by the method 
of Bradford using Bio-Rad Protein Assay reagents (Bio-Rad) in a microtiter assay plate. Total cellular 
protein (30ug) was electrophoresed on 12.5% SDS-PAGE gel, transferred to a polyvinylidine 
difluoride membrane (Amersham, Arlington Heights, IL) by electroblotting overnight. Membranes 
were blocked with 10% electrophoresis grade biotin-depleted non-fat dry milk (BioRad) in 1 X PBS 
(10 mM Tris pH 7.5, 100 mM NaCl, 0.1% Tween-20), rinsed in PBS, probed with monoclonal mouse 
anti-human bcl-2, Cyclin A and D (BD Bioscience San Diego, CA) using 1:1,000 dilution, and washed 
3 times in PBS. The secondary antibody was HRP-conjugated goat anti-mouse whole IgG used at 
1:1,000 (Transduction Laboratories). All antibodies were diluted in 1% milk in TBS. Membranes were 
washed three times. Detection of membrane-bound proteins was carried out by enhanced 
chemiluminesence with an ECL reagent kit (using 0.06 mL/cm
2 of reagent) and Hybond Int. J. Environ. Res. Public Health 2010, 7          
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autoradiography film (both Amersham). Biotinylated standards were used for molecular weight 
determination and were detected with 1:3,000 streptavidin-horseradish peroxidase (Amersham).  
 
3. Results 
 
 Xenoestrogen Effects on HeLa Cell Proliferation 
 
Study results show compound-specific effects on accumulation of viable HeLa cell mass.   
17-β-estradiol and TCDD were used as representative controls of endogenous and environmental   
anti-estrogen compounds. In Figure 1, coumestrol, DDT and TCDD exhibited concentration dependent 
(20 to 120 nM) suppression on HeLa cell proliferation, indicating the cytotoxic effects of   
17-β-estradiol [36-39]. Viable cell mass was assessed by MTT assay (see Methods). Change in total 
cell number was confirmed in cell cultures by enumeration (not shown). * p < 0.05 was determined 
using ANOVA with Bonferroni correction for multiple comparisons.  
Figure 1. HeLa cell viability over 72 h exposure to 20 to 120nM 17-β-estradiol (E), DDT 
(D), Coumestrol, TCDD vs. control/solvents (C). 17-β-estradiol, DDT, Coumestrol and 
TCDD had profound effects on HeLa cell proliferation. 
 
 
Estrogen Suppresses Bcl-2 in a Dose-Dependent Manner 
 
Members of the bcl-2 family are crucial regulators of apoptosis
 in mammalian cells. The bcl-2 
family includes antiapoptotic
 proteins, such as Bcl-2, and proapoptotic proteins, such as
 Bax. Since 
estrogen induced apoptosis is dependent on time and dose, we first tested bcl-2 response to estrogen. 
HeLa cells demonstrated a dose-dependent
 decrease (20, 40, 60, 80, 90 nM) in the expression of the 
antiapoptotic Bcl-2 protein upon estrogen treatment (Figure 2). 
20  40 60 80  100 120 Int. J. Environ. Res. Public Health 2010, 7          
 
2049
Figure 2. Expression of bcl-2 in HeLa cells exposed to17-β-estradiol (20, 40, 60, 80, and 
90 nM) for 24 h. Western blot analysis of bcl-2 expression was performed as indicated in 
the Materials and Methods. Beta actin expression was used to assess equal lane loading. 
 
Xenoestrogen Modulation of Cell Cycle Phase Distribution 
 
Cell accumulation or growth is a homeostatic balance between proliferation and apoptosis [42,43]. 
Questions have been raised regarding the MTT assay as a measure of viable cell mass, especially for 
xenoestrogens [44]. Therefore, xenoestrogen effects on cell cycle phase distribution in HeLa cells was 
also assessed by propidium iodide (PI) staining [38,39]. Representative cell cycle histograms for   
17-β-estradiol, coumestrol, DDT and TCDD are shown in Figure 3, 17-β-estradiol and coumestrol had 
significant cell cycle phase effect on actively growing HeLa cells, causing redistribution from G0/G1 
to apoptosis (p < 0.01), whereas TCDD and DDT had minimal effect, when analyzed by PI staining. 
Figure 3. Histograms showing representative cell cycle phases of β-estradiol, coumestrol, 
DDT and TCDD treated HeLa cells for 24 H. Flow microfluorometry was performed as 
indicated in the Materials and Methods. Percent of apoptotic cells (labeled M4) is   
β-estradiol ~17%, DDT ~5%, Coumestrol￿ shown for comparison. Control ~0.2%, 
17 ~ 30% and TCDD ~3%. 
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Xenoestrogen Suppression of Bcl-2 and Stimulation of Cyclin A and D 
 
Bcl-2, Cyclin A and D cell regulatory proteins modulate cell cycle progression and   
apoptosis [42,43,46]. Given the observed effects of xenoestrogens on HeLa cell proliferation and cell 
cycle distribution, examination of bcl-2, Cyclin A and D protein levels was performed. As shown in 
representative Western blots (Figure 4; n = 3), xenoestrogens DDT, coumestrol, and 17-β-estradiol 
suppressed bcl-2 protein whereas, anti-estrogen, TCDD did not have a significant effect on bcl-2 
expression as compared to the control. DDT, coumestrol and TCDD increased Cyclin A and D protein 
levels to variable degrees in HeLa cells (Figures 5 and 6 respectively). These preliminary results are 
consistent with recent reports of potential modulation of bcl-2 by xenoestrogens [47-50], supporting 
the concept that xenoestrogens may modulate cancer cell biology through associated changes in bcl-2. 
Figure 4. Expression of bcl-2 protein in β-estradiol, DDT, coumestrol, and TCDD treated 
HeLa cells for 24 h. Western blot analysis of bcl-2 expression was performed as indicated 
in the Materials and Methods. β actin expression was used to assess equal lane loading. 
 
Figure 5. Expression of cyclin A protein in β-estradiol, DDT, coumestrol, and TCDD 
treated HeLa cells for 24 h. Western blot analysis of cyclin A expression was performed as 
indicated in the Materials and Methods. β actin expression was used to assess equal   
lane loading. 
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Figure 6. Expression of cyclin D protein in β-estradiol, DDT, coumestrol, and TCDD 
treated HeLa cells for 24 h. Western blot analysis of cyclin D expression was performed as 
indicated in the Materials and Methods. β actin expression was used to assess equal   
lane loading. 
 
 
4. Discussion 
 
In this study we examined xenoestrogen’s direct actions on proliferation, cell cycle phase 
distribution and apoptosis in Hela cells. While the HeLa cells used in this study are transformed and 
may not accurately reflect primary cervical cells in vivo, they serve as a useful model and a basis for 
further examination of direct effects of xenoestrogens. As others have reported [51,52], and we 
confirmed in this investigation, xenoestrogens have a marked overall suppression effect on HeLa   
cell proliferation. 
Xenoestrogen concentration used in this study, while supraphysiological, were comparable to those 
known to maximally stimulate estrogen receptor transcriptional activity [53]. Based on previous in 
vitro studies, xenoestrogens in the range of 20 nM to 120 nM demonstrate maximal effects on cell 
apoptosis and cell differentiation [28,54] and these high concentrations may be required in transformed 
cell lines. Although the concentrations in this investigation are some what higher that those found in 
the environment, long-term bioacccumulative actions may be anticipated to affect cancer cell biology. 
With receptor binding affinities up to 10,000 fold weaker than endogenous estrogens, the 
environmental impact of xenoestrogens is the subject of scientific and societal debate [51,55]. These 
preliminary studies of representative xenoestrogens have been designed to detect and dissect potential 
effects on HeLa cells.  
Xenoestrogens are environmental hormones or compounds that exhibit estrogenic activity. They 
may interact with or disrupt endogenous estrogenic activity, and, as suggested by some investigations, 
may have implications for health and disease [27,56]. In the present study, estrogen, coumestrol and 
DDT, but not TCDD were shown to variably but significantly suppress bcl-2 protein expression in 
HeLa cells. However, DDT, coumestrol and TCDD upregulated cyclin A and D protein expression. 
The variability is likely due to xenoestrogenic potency with respect to estrogenic activity [57,58], as 
well as possible differences in mechanisms of action [23-25]. Nevertheless, our experimental data 
suggest that these specific xenoestrogens, at high concentrations, have specific effects on HeLa cells.  
While concentrations of xenoestrogens used in this study may exceed those detected in the 
environment and the general population, chronic, low level of exposure is known to have biological Int. J. Environ. Res. Public Health 2010, 7          
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effects [58,60]. The purpose of this investigation was to identify possible mechanisms of HeLa cell 
modulation and not necessarily establish environmental exposure-based cause-and-effect evidence. 
Furthermore, acute in vitro effects cannot be adequately extrapolated to chronic, low dose exposure in 
vivo effects. Hence, results in the current study should be interpreted with utmost caution. Observed 
effects occurred only in selected xenoestrogens, implying that effects may be compound-specific and 
that broad generalization for individual compounds are not appropriate. Data in the current study 
suggest a direct induction of apoptosis by estrogen and coumestrol, but not DDT AND TCDD. While 
verification and extension of our results is needed, the apoptosis induced in estrogen and coumestrol 
suggests at least one of potential effects, by which some xenoestrogens affect cell viability and induce 
cell death.  
The effects observed in the current study may be estrogen receptor dependent or independent [61]. 
Jeon and Esser have shown that TCDD elicits its biological function through binding of the AHR to 
distal DNA motifs [62]. However, xenoestrogens may also have AHR receptor independent effects on 
hela cells and xenoestrogen mechanisms of action are likely pleiotropic [63]. Delineating 
xenoestrogen-mediated effects through the ER or AHR is pivotal to understanding molecular 
mechanisms of xenoestrogens, but is beyond the scope of this initial study.  
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